As GLP-1 and GLP-2 have become important targets in the treatment of type 2 diabetes, obesity and malabsorptive conditions 16,17,62 , we therefore characterized gut microbiome signatures in DIO mice treated with liraglutide, a selective GLP-1 receptor agonist, or GUB09-145, a potent dual GLP-1/GLP-2 agonist 26
Moreover, all included studies were RCTs
However, this should be approached cautiously and only after extended plateaus (6+ weeks of stable weight despite consistent protocol adherence)
[PubMed] Brustolin, S., Giugliani, R., & Flix, T
If you let yourself get over-hungry, youll feel less in control and more likely to overeat. Additional repor ting by Jordan M